Soraya Madani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND To date, no treatment for neuromyelitis optica (NMO) has been granted regulatory approval, and no controlled clinical studies have been reported. OBJECTIVE To design a placebo-controlled study in NMO that appropriately balances patient safety and clinical-scientific integrity. METHODS We assessed the "standard of care" for NMO to establish(More)
  • 1